Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026)

Ardelyx (ARDX) posted Cash from Financing Activities of $5.4 million for Q1 2026, up 877.02% on a QoQ basis from $557000.0 in Q4 2025, and up 267.21% year-over-year from $1.5 million in Q1 2025.

Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ardelyx's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $5.4 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 267.21% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.5 million (up 6.11% YoY) and the FY2025 annual result came in at $54.5 million, down 48.86% from the prior year.
  • Cash from Financing Activities was $5.4 million for Q1 2026 at Ardelyx, up from $557000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $57.9 million in Q3 2023 and bottomed at -$63000.0 in Q1 2022.
  • A 5-year average of $22.8 million and a median of $18.8 million in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 100.18% — and 2023, when it jumped 80923.81%.
  • Ardelyx's Cash from Financing Activities stood at $18.8 million in 2022, then jumped by 38.33% to $26.0 million in 2023, then surged by 89.75% to $49.3 million in 2024, then plunged by 98.87% to $557000.0 in 2025, then soared by 877.02% to $5.4 million in 2026.
  • Business Quant data shows ARDX's Cash from Financing Activities at $5.4 million in Q1 2026, $557000.0 in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 30.14 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 53,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 68.63 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 238.74 Mn
10 Ardelyx 1.24 Bn 999.81 Mn 89.66 Mn 5.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.44 Mn
Mar 31, 2026 5.44 Mn
Dec 31, 2025 557,000.00
Dec 31, 2025 557,000.00
Sep 30, 2025 2.81 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 49.66 Mn
Jun 30, 2025 49.66 Mn
Mar 31, 2025 1.48 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 49.31 Mn
Dec 31, 2024 49.31 Mn
Sep 30, 2024 2.70 Mn
Sep 30, 2024 2.70 Mn
Jun 30, 2024 1.61 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 52.97 Mn
Mar 31, 2024 52.97 Mn
Dec 31, 2023 25.99 Mn
Dec 31, 2023 25.99 Mn